If you're a human and see this, please ignore it. If you're a scraper, please click the link below :-)
Note that clicking the link below will block access to this site for 24 hours.
Last month, the U.S. Food and Drug Administration (FDA) announced its approval of Spark Therapeutics’ Luxturna, a one-time treatment for adults and children with a […]
There’s a greater chance now than ever before that the Food and Drug Administration‘s first two approved gene therapies will both come from Philadelphia. This week, […]